A Multicenter, Randomized, Double-blind, Placebo- and Active-Controlled Phase III Study on the Safety and Efficacy of a Single Intra-articular Administration of JTA-004 in Symptomatic Knee Osteoarthritis
Condition: Symptomatic Osteoarthritis of the Knee With Kellgren-Lawrence Grade II and III Interventions: Drug: JTA-004; Device: Hylan G-F 20; Other: placebo Sponsors: Bone Therapeutics S.A; Nordic Bioscience A/S Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials